Cargando…

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

OBJECTIVES: Well differentiated keratinized squamous component as a part of urothelial carcinoma can be easily appreciated; however non-keratinizing squamous differentiation closely resembles urothelial differentiation. In addition prognostic significance of CK 5/6 expression in the absence of appar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Atif Ali, Hussain, Zubaida Fida, Irfan, Muhammad, Edhi, Muhammad Muzzammil, Kanwal, Sarah, Faridi, Naveen, Khan, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870198/
https://www.ncbi.nlm.nih.gov/pubmed/29587848
http://dx.doi.org/10.1186/s13104-018-3319-4
_version_ 1783309428332691456
author Hashmi, Atif Ali
Hussain, Zubaida Fida
Irfan, Muhammad
Edhi, Muhammad Muzzammil
Kanwal, Sarah
Faridi, Naveen
Khan, Amir
author_facet Hashmi, Atif Ali
Hussain, Zubaida Fida
Irfan, Muhammad
Edhi, Muhammad Muzzammil
Kanwal, Sarah
Faridi, Naveen
Khan, Amir
author_sort Hashmi, Atif Ali
collection PubMed
description OBJECTIVES: Well differentiated keratinized squamous component as a part of urothelial carcinoma can be easily appreciated; however non-keratinizing squamous differentiation closely resembles urothelial differentiation. In addition prognostic significance of CK 5/6 expression in the absence of apparent squamous differentiation is still unclear. Therefore, in the present study we aimed to evaluate the frequency of CK 5/6 expression in 127 cases of urothelial carcinoma and its prognostic significance in loco-regional population. RESULTS: Positive CK5/6 expression was noted in 6.3% (8 cases) and 13.4% (17 cases) revealed focal positive CK 5/6 expression. On the other hand, 80.3% (102 cases) showed negative CK5/6 staining. Significant association of CK5/6 expression was noted with tumor grade and muscularis propria invasion, however no significant association was noted with overall and disease free survival. On the basis of the results of our study we can conclude that CK5/6 is an independent prognostic biomarker in urothelial carcinoma and therefore can be used in the prognostic stratification of the patients with bladder cancer.
format Online
Article
Text
id pubmed-5870198
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58701982018-03-29 Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis Hashmi, Atif Ali Hussain, Zubaida Fida Irfan, Muhammad Edhi, Muhammad Muzzammil Kanwal, Sarah Faridi, Naveen Khan, Amir BMC Res Notes Research Note OBJECTIVES: Well differentiated keratinized squamous component as a part of urothelial carcinoma can be easily appreciated; however non-keratinizing squamous differentiation closely resembles urothelial differentiation. In addition prognostic significance of CK 5/6 expression in the absence of apparent squamous differentiation is still unclear. Therefore, in the present study we aimed to evaluate the frequency of CK 5/6 expression in 127 cases of urothelial carcinoma and its prognostic significance in loco-regional population. RESULTS: Positive CK5/6 expression was noted in 6.3% (8 cases) and 13.4% (17 cases) revealed focal positive CK 5/6 expression. On the other hand, 80.3% (102 cases) showed negative CK5/6 staining. Significant association of CK5/6 expression was noted with tumor grade and muscularis propria invasion, however no significant association was noted with overall and disease free survival. On the basis of the results of our study we can conclude that CK5/6 is an independent prognostic biomarker in urothelial carcinoma and therefore can be used in the prognostic stratification of the patients with bladder cancer. BioMed Central 2018-03-27 /pmc/articles/PMC5870198/ /pubmed/29587848 http://dx.doi.org/10.1186/s13104-018-3319-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Hashmi, Atif Ali
Hussain, Zubaida Fida
Irfan, Muhammad
Edhi, Muhammad Muzzammil
Kanwal, Sarah
Faridi, Naveen
Khan, Amir
Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title_full Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title_fullStr Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title_full_unstemmed Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title_short Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
title_sort cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870198/
https://www.ncbi.nlm.nih.gov/pubmed/29587848
http://dx.doi.org/10.1186/s13104-018-3319-4
work_keys_str_mv AT hashmiatifali cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT hussainzubaidafida cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT irfanmuhammad cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT edhimuhammadmuzzammil cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT kanwalsarah cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT faridinaveen cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis
AT khanamir cytokeratin56expressioninbladdercancerassociationwithclinicopathologicparametersandprognosis